SciELO - Scientific Electronic Library Online

 
vol.24 número5Reação capsular aos revestimentos de próteses mamárias de silicone texturizado e espuma de silicone em ratosEfeito de um extrato de Aloe vera na biodistribuição do pertecnetato de sódio (Na99mTcO4) em ratos índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

Links relacionados

Compartilhar


Acta Cirurgica Brasileira

versão On-line ISSN 1678-2674

Acta Cir. Bras. vol.24 no.5 São Paulo set./out. 2009

http://dx.doi.org/10.1590/S0102-86502009000500007 

7 - ORIGINAL ARTICLE
EFFECTS OF DRUGS

 

Farnesol inhibits cell proliferation and induces apoptosis after partial hepatectomy in rats1

 

Farnesol inibe a proliferação celular e induz a apoptose após a hepatectomia parcial em ratos

 

 

Carlos Eduardo Andrade ChagasI; Alessandra VieiraII; Thomas Prates OngIII; Fernando Salvador MorenoIV

IRD, MSc, Fellow PhD degree, Faculty of Pharmaceutical Sciences, USP, Sao Paulo, Brazil
IIBS, MSc, Fellow PhD degree, Faculty of Pharmaceutical Sciences, USP, Sao Paulo, Brazil
IIIPharm. D, PhD, Assistant Professor, Department of Food and Experimental Nutrition, Phaculty of Pharmaceutical Sciences, USP, Sao Paulo, Brazil
IVMD, PhD, Full Professor, Department of Food and Experimental Nutrition, Faculty of Pharmaceutical Sciences, USP, Sao Paulo, Brazil

Correspondence

 

 


ABSTRACT

PURPOSE: To study farnesol (FOH) effects on liver regeneration after 70% partial hepatectomy (PH) in rats.
METHODS: Animals received FOH (25 mg/100 g body weight/day) or corn oil (CO, 0.25 mL/100 g body weight/day, controls). After a 2 week-treatment, all animals were subjected to PH and euthanized at different time points (0 h, 0.5 h, 4 h, 8 h, 18 h and 24 h) after surgery. Hepatic cell proliferation (PCNA positive nuclei) and apoptosis (fluorescence microscopy) were evaluated.
RESULTS: Compared to CO treatment, FOH treatment inhibited (p<0.05) cell proliferation at 24h (S phase of the cell cycle) after PH. This was preceded by an induction of apoptosis 0.5 h (p<0.05; G0/G1 transition phase) after surgery.
CONCLUSION: The results of the present study suggest that apoptosis induction could be associated with the reduced number of cells at the S phase observed in FOH group. These novel in vivo data reinforce FOH as a promising chemopreventive and therapeutic agent against cancer.

Key words: Farnesol. Hepatectomy. Cell Proliferation. Apoptosis. Rats.


RESUMO

OBJETIVO: Estudar o efeito do farnesol (FOH) durante a regeneração hepática em ratos submetidos à Hepatectomia Parcial (HP) a 70%.
MÉTODOS: Os animais foram tratados com FOH (25 mg/100g de peso corpórel/dia) ou óleo de milho (OM, 0,25 mL/100g de peso corpóreo/dia, grupo controle). Depois de 2 semanas de tratamento, todos os animais foram submetidos à HP e eutanaziados em diferentes momentos (0h, 30min., 4h, 8h, 18h, 24h.) após o procedimento cirúrgico. Foi avaliada a proliferação celular (imunohistoquímica para PCNA) e a apoptose (microscopia de fluorescência).
RESULTADOS: Em comparação aos animais controles, animais tratados com FOH apresentaram menor (p<0,05) proliferação celular 24h. (fase S do ciclo celular) após a HP. Tal efeito foi precedido de uma indução de apoptose 30min. (p<0,05; transição entre as fases G0/G1 do ciclo celular) após a cirurgia.
CONCLUSÃO: Os resultados do presente estudo sugerem que a indução da apoptose pode estar associada com o menor número de células na fase S observadas nos animais tratados com FOH. Essa nova evidência in vivo reforça o farnesol como um promissor agente preventivo e terapêutico contra o câncer.

Descritores: Farnesol. Hepatectomia. Proliferação de Células. Apoptose. Ratos.


 

 

Introduction

Cancer is an important global public health problem. The American Cancer Society projected 1,437,180 new cancer cases and 565,650 deaths form cancer in 20081. Despite advances in therapy, prognosis for patients with cancer remains poor. Thus chemoprevention is considered a relevant strategy for cancer control2.

Diet-derived isoprenoids present inhibitory effect against colon3,4, pancreas5,6 and liver7,8 carcinogenesis. They comprise a class of substances with over 20,000 constituents widely distributed in fruits and vegetables. Farnesol (FOH), a 15-carbon isoprenoid present in orange peel and lemon-grass oil and strawberries, has been considered a promising cancer chemopreventive8,9 and therapeutic agent10. Although FOH inhibited cell proliferation and induced apoptosis in vitro, in vivo information is scarce11. In rodents, these actions were observed during chemically induced pancreas5,6 and liver8 carcinogenesis, but not in models specifically designed for the study of cell proliferation.

The 70% partial hepatectomy (PH) is considered a classic, highly regulated and orchestrated model for the study of cell proliferation during liver regeneration12. After PH, most remaining hepatocytes promptly enter and progress in the cell cycle in a synchronous manner. The first stage (priming), in which hepatocytes undergo transition from resting state (G0) to one in which they become capable to proliferate (G1), lasts 4-6 h after PH14. Then, these primed hepatocytes enter a progression stage, with DNA synthesis starting around 18 h and peaking at 24 h after PH12-14. The objective of the present study was to investigate the effect of FOH administration in rats submitted to PH, a synchronized and well caracterized model for the study of cell proliferation.

 

Methods

Chemicals

FOH (trans, trans-3, 7, 11-trimethyl-2, 6, 10-dodecatrien-1-ol; 96%) was purchased from Aldrich. 3,3´-diaminobenzidine and bovine serum albumin were purchased from Sigma. The commercial diet was purchased from Purina®. Corn oil (CO) was Mazola®. Polyclonal anti-proliferative cell nuclear antigen (PCNA) rat antibody, secondary biotinylated antibody and streptavidin-biotin-peroxidase complex were purchased from Dako.

Animals and treatment

Male Wistar rats from the colony of the Faculty of Pharmaceutical Sciences, initially weighing 50 g maintained in cages with four animals, at constant temperature (22ºC), with 12 h light-dark cycle and receiving water and commercial diet ad libitum, were used.

Figure 1 illustrates the experimental design. At the end of a 7-day acclimatization period, 102 animals were randomly divided into 2 experimental groups. FOH group received FOH (25 mg/100 g bw) dissolved in CO (0.25 mL/100 g bw). CO group (control) received only CO. Both treatments were performed by gavage daily for 2 consecutive weeks. Afterwards, all animals were submitted to a 70% PH as previously described15 and euthanized at 0 h, 0.5 h, 4 h, 8 h, 18 h and 24 h after surgery. The last dose of FOH was administrated 2 h before euthanasia. The study was carried out within the guidelines of the Brazilian College of Animal Experiments (COBEA) and was approved by the Faculty of Pharmaceutical Sciences Ethic Committee for the Care and Use of Laboratory Animals (protocol number 16).

 

 

Hepatic cell proliferation analysis

To evaluate cell proliferation, representative fragments of each liver lobe were fixed in methacarn solution (60% methanol, 30% chloroform and 10% glacial acetic acid) for 24 h and included in paraffin. Histological sections of 5 µm were processed in order to detect PCNA-positive hepatocytes as described by Fonseca et al.16. Basically, after paraffin removal, endogenous peroxidase was blocked by 20% hydrogen peroxide in methanol for 0.5 h. Thereafter, the sections were incubated overnight at 4ºC with primary anti-PCNA rat antibody at a 1:1600 dilution in 1% bovine serum albumin. Finally, the sections were incubated for 1 h with secondary biotinylated antibody and thereafter the streptavidin-biotin-peroxidase complex was applied. Peroxidase binding sites were detected by incubation with 3,3´-diaminobenzidine (0.5%) and hydrogen peroxide (0.1%) dissolved in phosphate buffer saline (PBS), for 2 min at room temperature. Sections were counterstained with hematoxylin. The entire liver section was analyzed using light microscope. Cell proliferation index (CPI) was expressed as the number of PCNA-positive nuclei/mm2 histological liver section8.

Hepatic apoptosis evaluation

Hepatic apoptotic bodies (AB) were quantified by fluorescence microscopy as previously described8 using a Nikon microscope equipped with an epifluorescence unit. This method is based on the strong eosin fluorescence of AB in hematoxylin and eosin (H&E) stained liver tissues submitted to blue light (450-490 nm). Identification of AB was confirmed by switching the microscope system from blue to transmitted light and using morphological criteria established by Goldsworth et al.17. AB were represented by acidophilic bodies with fragmentation or lack of chromatin accompanied by cytoplasmatic condensation and/or fragmentation17. If single cells or clusters of directly neighbouring cell contained multiple AB, these were assumed to be derived from the same apoptotic cell and were counted as only one event. The entire liver section was analyzed. Apoptotic index (AI) was expressed as the number of hepatic AB/mm2 of histological section8.

Statistical analysis

Sigma Stat 2.0 program was used for statistical analysis. For all analyzed parameters a two-way ANOVA followed by a Tukey test was performed in order to identify any significant differences between CO and FOH group in all euthanasia time points. In all cases a level of significance of p < 0.05 was applied.

 

Results

Absolute and relative liver weights

Absolute and relative liver weights of rats treated with FOH or CO and submitted to 70% PH are shown in Table 1. No statistically significant (p > 0.05) differences were observed between experimental groups in all euthanasia time-points regarding absolute and relative liver weights. These results suggest that FOH did not present toxicity. FOH dosage was based on our previous study in which it did not present any apparent toxicity when administered during 8 consecutive weeks to rats submitted to a hepatocarcinogenesis model8.

 

 

FOH effects on hepatic cell proliferation and apoptosis

Figure 2 shows CPI of animals of FOH and CO groups. Until 18 h after surgery no statistically significant differences (p > 0.05) were observed regarding FOH and CO groups CPI. In CO group, the highest CPI was observed 24 h after surgery. Compared to CO group, FOH group presented smaller (p < 0.05) CPI 24 h after PH.

 

 

In the present study apoptosis was evaluated by counting AB using fluorescence microscopy8. Advantages of this method are the fast identification of AB due to their strong fluorescence in H&E-stained liver sections and increased sensitivity, since small fluorescent AB, usually not recognized by transmitted light microscopy, can also be identified8. Figure 3 shows an example of a fluorescent hepatic AB stained with H&E. Figure 4 shows AI of animals of FOH and CO groups. Compared to CO group, FOH group presented higher (p < 0.05) AI 0.5 h after PH. No differences (p > 0.05) were observed between FOH and CO groups in the other euthanasia time-points.

 

 

Discussion

The effects of chemopreventive agents on cell proliferation and apoptosis can be investigated in detail using 70% PH, a classic and synchronous model of liver regeneration12. Since hepatic regeneration in rodents is similar to that observed in humans, the results obtained from rodents can be also applicable to the human liver18. The priming stage (G0/G1 transition) comprises the first 4-6 h, followed by progression that lasts 12-16 h. Hepatic DNA synthesis (S phase) starts around 18 h and peaks at 24 h after surgery12-14.

Cell proliferation has been suggested to involve a regulated passage through some checkpoints which ensure the proper timing of cell cycle events19. Compounds that prevent cell cycle progression can be used as negative regulators of cell proliferation in proliferative diseases such as cancer20. FOH induced G0/G1 arrest which leaded to apoptosis and inhibition of cell proliferation in lung and leukemia cells21,22. In the present study, rats treated with FOH presented a reduced number of PCNA positive nuclei 24 hours (S phase) after 70% PH. In addition, FOH effect on cell proliferation was preceded by apoptosis induction started 0.5 h (G0/G1 transition) after surgical procedure.

Apoptosis is considered an ideal way of eliminating undesired or genetically altered cells without the induction of inflammatory response22. Arsenite23, manganese24 and 5-(N,N-hexamethylene)-amiloride25, when administered subcutaneously after PH, induced apoptosis 4h after surgery. Thus considering the present and previously data23-25 it seems that apoptosis occurs preferentially during the priming stage of liver regeneration. The differences regarding the time of apoptosis induction between these above mentioned studies and the present study could be related to the fact that FOH administration by gavage was started 2 weeks before the PH which could increase the hepatic concentration of this isoprenoid.

We suggest that similarly to in vitro studies, in the present study FOH induced a G0/G1 cell cycle arrest that leaded to apoptosis induction after PH. This could be associated to the reduced number of PCNA positive cells at the S phase as also described for retinoic acid14, quercetin26 and 5-(N,N-hexamethylene)-amiloride25. In those studies rats submitted to PH and treated with these substances presented inhibition of DNA synthesis that was also preceded by apoptosis induction starting during early G1 phase.

In summary, the results of the present study reinforce FOH as an attractive candidate for cancer prevention8,9 and therapy10. In order to provide further information regarding FOH actions on cell cycle phases, future studies could focus on the molecular pathways involved in both apoptosis and cell proliferation in vivo.

 

Conclusion

The farnesol induces apoptosis and decreases cell proliferation during liver regeneration after partial hepatectomy.

 

Acknowledgement

The authors would like to thanks Miss Silvania M.P. Neves for providing the care and maintenance of the animals.

 

References

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thum MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.         [ Links ]

2. Sporn MB, Suh N. Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer. 2002;2(7):537-43.         [ Links ]

3. Wargovich MJ, Jimenez A, Mckee K, Steele VE, Velasco M, Woods J, Price R, Gray K, Kelloff GJ. 2000. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis. 2000;21(6):1149-55.         [ Links ]

4. Rao CV, Newmark HL, Reddy BS. Chemopreventive effect of farnesol and lanosterol on colon carcinogenesis. Cancer Detect Prev. 2002;26(6):419-25.         [ Links ]

5. Burke YD, Stark MJ, Roach SL, Sen SE, Crowell PL. Inhibition of pancreatic cancer grown by the dietary isoprenoids farnesol and geraniol. Lipids. 1997;32(2):151-6.         [ Links ]

6. Burke YD, Ayoubi AS, Werner SR, McFarland BC, Heilman DK, Ruggeri BA, Crowell PL. Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention. Anticancer Res. 2002;22(6A):3127-34.         [ Links ]

7. Espindola RM, Mazzantini RP, Ong TP, de Conti A, Heidor R, Moreno FS. Geranylgeraniol and ß-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-KB activation. Carcinogenesis. 2005;26(6):1091-9.         [ Links ]

8. Ong TP, Heidor R, de Conti A, Dagli ML, Moreno FS. Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis. 2006;27(6):1194-203.         [ Links ]

9. Horn TL, Long L, Cwik MJ, Morrissey RL, Kapetanovic IM, McCormick DL. Modulation of hepatic and renal drug metabolizing enzyme activities in rat by subchronic administration of farnesol. Chem Biol Interact. 2005;152(2-3)152:79-99.         [ Links ]

10. Scheper MA, Shirtliff ME, Meiller TF, Peters BM, Jabra-Rizk MA. Farnesol, a fungal quorum-sensing molecule triggers apoptosis in human oral squamous carcinoma cells. Neoplasia. 2008;10(9):954-63.         [ Links ]

11. Mo H, Elson CE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med. 2004;229(7):567-85.         [ Links ]

12. Fausto N. Liver regeneration. J Hepatol. 2000;32(1 Suppl):19-31.         [ Links ]

13. Tarlá MR, Ramalho FS, Ramalho LNZ, Castro e Silva T, Brandão, DF, Ferreira J, Castro e Silva O, Zucoloto, S. A molecular view of liver regeneration. Acta Cir Bras. 2006;21(Suppl 1):58-62.         [ Links ]

14. Ozek A, Tsukamoto I. Retinoic acid repressed the expression of c-fos and c-jun and induced apoptisis in regeneration rat liver after partial hepatectomy. Biochem Biophys Acta. 1999;1450(3):308-19.         [ Links ]

15. Higgins GM, Anderson RM. Experimental pathology of the liver. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol. 1931;12:186-202.         [ Links ]

16. Fonseca EMAV, Chagas CEA, Mazzantini RP, Heidor R, Ong TP, Moreno FS. All-trans and 9-cis retinoic acids, retinol and beta-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage. Carcinogenesis. 2005;26(11):1940-6.         [ Links ]

17. Goldsworth TL, Fransson-Steen R, Maronpot RR. Importance of and approaches to quantification of hepatocytes apoptosis. Toxicol Pathol. 1996;24(1):24-35.         [ Links ]

18. Fausto N. Liver regeneration: from laboratory to clinic. Liver Transplant. 2001;7(10):835-44.         [ Links ]

19. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science. 1989;246(4930):629-34.         [ Links ]

20. Chen HW, Huang HC. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol. 1998;124(6):1029-40.         [ Links ]

21. Wright MM, McMaster CR. Phospholipid synthesis, diacylglycerol compartmentation, and apoptosis. Biol Res. 2002;35(2):223-9.         [ Links ]

22. Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Rubini C, Mariggio MA, Procaccini M, Ferrari F, De Rosa G, Altieri DC. Survivin expression in oral squamous cell carcinoma. Br J Cancer. 2003;89(12):2244-8.         [ Links ]

23. Suzuki T, Tsukamoto I. Arsenite induced apoptosis in hepatocytes through an enhancement of the activation of Jun N-terminal kinase and p38 mitogen-activated protein kinase caused by partial hepatectomy. Toxicol Lett. 2006;165(3):257-64.         [ Links ]

24. Suzuki T, Tsukamoto I. Manganese-induced apoptosis in hepatocytes after hepatectomy. Eur J Pharmacol. 2005;525(1-3):48-53.         [ Links ]

25. Suzuki T, Tsukamoto I. Apoptosis induced by 5-(N,N-hexamethyllene)-amilorida in regeneration liver after partial hepatectomy. Eur J Pharmacol. 2004;503(1-3):1-7.         [ Links ]

26. Iwao K, Tsukamoto I. Quercetin inhibited DNA synthesis and induced apoptosis associated with increase in c-fos mRNA leval and the upregulation of p21WAK1CIP1 mRNA and protein expression during liver regeneration after partial hepatectomy. Biochim Biophys Acta. 1999;1427(1):112-20.         [ Links ]

 

 

Correspondence:
Prof. Fernando Salvador Moreno
Laboratory of Diet, Nutrition and Cancer
Av. Prof. Lineu Prestes, 580/Bloco 14
05508-900 Sao Paulo - SP Brazil
Phone: (55 11)3091-1492
Fax: (55 11)3815-4410
rmoreno@usp.br

Received: March 18, 2009
Review: May 12, 2009
Accepted: June 16, 2009
Conflict of interest: none
Financial source: FAPESP, CNPq and CAPES

 

 

How to cite this article
Chagas CEA, Vieira A, Ong TP, Moreno FS. Farnesol inhibits cell proliferation and induces apoptosis after partial hepatectomy in rats. Acta Cir Bras. [serial on the Internet] 2009 Sept-Oct;24(5). Available from URL: http://www.scielo.br/acb
* Color figures available from www.scielo.br/acb
1 Research performed at the Laboratory of Diet, Nutrition and Cancer, Department of Food and Experimental Nutrition, Faculty of Pharmaceutical Sciences, University of Sao Paulo (USP), Brazil.